Vermillion Inc is a diagnostic service and bio-analytic solutions provider company. It is engaged in the business of developing and commercializing diagnostic tests for the gynecologic disease. The company's products include OVA1, a blood test for the pre-surgical identification of women who are at high risk of having a malignant ovarian tumor. It serves clinical reference laboratories, hospital laboratories, and physician offices.
| Website: | www.vermillion.com |
| Email: | Arr@lifesciadvisors.com |
| Main Phone: | +1 512 519-0400 |
| Address: | 12117 Bee Caves Road, Building Three |
| Address 2: | Suite 100 |
| State: | TX |
| City / Town: | Austin |
| Country: | USA |
| Postal Code: | 78738 |
| Exchange: | NSC |
| CEO: | Valerie Palmieri |
| Employees: | 43 |
| NAICS: | Analytical Laboratory Instrument Manufacturing(334516) |
Vermillion's OVA1’s Celebrity Awareness Team continues to ignite the conversation about ovarian cancer with two new additions.
At www.ValuEngine.com we show that the Medical sector 13.6% overvalued with the medical Instruments industry 2.0% undervalued. All 12 stocks in today’s table have complete ValuEngine data and
The Dow Jones Industrial Average rallied from a low of 12751.51 to a high of 12858, but the daily chart remains negative. The NASDAQ rallied from a low of 2920.54 to a high of 1940.28, but the
Vermillion Inc is a diagnostic service and bio-analytic solutions provider company. It is engaged in the business of developing and commercializing diagnostic tests for the gynecologic disease. The company's products include OVA1, a blood test for the pre-surgical identification of women who are at high risk of having a malignant ovarian tumor. It serves clinical reference laboratories, hospital laboratories, and physician offices.
| Website: | www.vermillion.com |
| Email: | Arr@lifesciadvisors.com |
| Main Phone: | +1 512 519-0400 |
| Address: | 12117 Bee Caves Road, Building Three |
| Address 2: | Suite 100 |
| State: | TX |
| City / Town: | Austin |
| Country: | USA |
| Postal Code: | 78738 |
| Exchange: | NSC |
| CEO: | Valerie Palmieri |
| Employees: | 43 |
| NAICS: | Analytical Laboratory Instrument Manufacturing(334516) |
Vermillion's OVA1’s Celebrity Awareness Team continues to ignite the conversation about ovarian cancer with two new additions.
At www.ValuEngine.com we show that the Medical sector 13.6% overvalued with the medical Instruments industry 2.0% undervalued. All 12 stocks in today’s table have complete ValuEngine data and
The Dow Jones Industrial Average rallied from a low of 12751.51 to a high of 12858, but the daily chart remains negative. The NASDAQ rallied from a low of 2920.54 to a high of 1940.28, but the
| Last Price 0.78 | Change $ -0.0058 | Change % -0.74 | Tick N/A |
| Bid 0.50 | Bid Size 1,000.00 | Ask 1.00 | Ask Size 1,200.00 |
| Open 0.82 | High 0.82 | Low 0.76 | Prev Close 0.79 |
| Last Trade | Volume 502,624 | 52 Wk Hi 1.58 | 52 Wk Low 0.36 |
| Market Cap 75.9 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 97,286,157.00 | EPS (TTM) -0.18 | PE Ratio N/A | Exchange NCM |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 10 | 20 |
| Number of Buys | 10 | 20 |
| Number of Sells | 0 | 0 |
| Net Activity | 5344264 | 8061903 |
| Last 10 Buys | Shares |
|---|---|
| Henri George Schuler | 1,000 |
| Henri George Schuler | 1,000 |
| Henri George Schuler | 1,000 |
| Jack W Schuler | 1,000 |
| Henri George Schuler | 1,000 |
| Valerie Palmieri | 1,000 |
| Valerie Palmieri | 1,000 |
| Valerie Palmieri | 1,000 |
| Valerie Palmieri | 1,000 |
| Valerie Palmieri | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Carl Severinghaus | 1,000 |
| Carl Severinghaus | 1,000 |
| Carl Severinghaus | 1,000 |
| Gail S. Page | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 2.25 | 2.25 | 2.25 | 2.25 |
| Low Target Price Estimate | 2.25 | 2.25 | 2.25 | 2.25 |
| Mean Target Price Estimate | 2.25 | 2.25 | 2.25 | 2.25 |
| Standard Deviation | 0 | 0 | 0 | 0 |
| Date of Most Recent Estimate | 11/02/17 | 11/02/17 | 11/02/17 | 11/02/17 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 8-K | Report of unscheduled material events or corporate changes. | 4 | 2018-05-30 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 32 | 2018-05-14 |
| 8-K | Report of unscheduled material events or corporate changes. | 11 | 2018-05-14 |
| DEF 14A | Official notification to shareholders of matters to be brought to a vote (Proxy) | 81 | 2018-05-11 |
| 10-K/A | Amendment to a previously filed 10-K | 29 | 2018-04-30 |
| PRE 14A | Preliminary proxy statement providing notification matters to be brought to a vote | 81 | 2018-04-27 |
| SC 13D/A | Amendment to a SC 13D filing | 10 | 2018-04-23 |
| SC 13D/A | Amendment to a SC 13D filing | 8 | 2018-04-19 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-04-19 |
| SC 13D/A | Amendment to a SC 13D filing | 10 | 2018-04-19 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 0 | 1 | 1 | 1 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 1 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 3 | 1 | 1 | 1 |
© 2020 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
Gathering Data... Please wait